LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | R406 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4111 | 5013 | 0.8201 | 0.7563 |
MDA-MB-231 | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3702 | 5013 | 0.7384 | 0.6457 |
MDA-MB-231 | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4958 | 5013 | 0.9890 | 0.9851 |
MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1176 | 5013 | 0.2346 | -0.0367 |
MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1119 | 5013 | 0.2232 | -0.0521 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 3604 | 5013 | 0.7189 | 0.6193 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3998 | 5013 | 0.7975 | 0.7258 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4489 | 5013 | 0.8954 | 0.8583 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1124 | 5013 | 0.2242 | -0.0507 |
MDA-MB-231 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4664 | 5013 | 0.9303 | 0.9056 |
MDA-MB-231 | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1702 | 5013 | 0.3395 | 0.1054 |
MDA-MB-231 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 2940 | 5013 | 0.5865 | 0.4400 |
MDA-MB-231 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4219 | 5013 | 0.8416 | 0.7855 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4834 | 5013 | 0.9643 | 0.9516 |
MDA-MB-231 | JNK-9L | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1674 | 5013 | 0.3340 | 0.0980 |
MDA-MB-231 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3842 | 5013 | 0.7665 | 0.6837 |
MDA-MB-231 | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4650 | 5013 | 0.9275 | 0.9018 |
MDA-MB-231 | LDN-193189 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4068 | 5013 | 0.8115 | 0.7447 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 5005 | 5013 | 0.9984 | 0.9979 |
MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4734 | 5013 | 0.9443 | 0.9245 |
MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP5 | 72 | hr | 1311 | 968 | 5013 | 0.1931 | -0.0928 |
MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1311 | 904 | 5013 | 0.1804 | -0.1101 |
MDA-MB-231 | MK2206 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4294 | 5013 | 0.8566 | 0.8058 |
MDA-MB-231 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4307 | 5013 | 0.8592 | 0.8093 |
MDA-MB-231 | Nilotinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4634 | 5013 | 0.9244 | 0.8977 |